These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 19079906)

  • 21. Curcumin and the cellular stress response in free radical-related diseases.
    Calabrese V; Bates TE; Mancuso C; Cornelius C; Ventimiglia B; Cambria MT; Di Renzo L; De Lorenzo A; Dinkova-Kostova AT
    Mol Nutr Food Res; 2008 Sep; 52(9):1062-73. PubMed ID: 18792015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels.
    Weiskirchen R; Mahli A; Weiskirchen S; Hellerbrand C
    Front Physiol; 2015; 6():140. PubMed ID: 25999863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rosiglitazone: possible complications and treatment of non-alcoholic steatohepatitis (NASH).
    Henriksen JH; Ring-Larsen H
    J Hepatol; 2008 Jan; 48(1):174-6. PubMed ID: 18022724
    [No Abstract]   [Full Text] [Related]  

  • 24. Insulin resistance and oxidative stress: two therapeutic targets in non-alcoholic steatohepatitis.
    Voican CS; Perlemuter G
    J Hepatol; 2011 Feb; 54(2):388-91. PubMed ID: 21112115
    [No Abstract]   [Full Text] [Related]  

  • 25. CerS2 Haploinsufficiency Inhibits β-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance.
    Raichur S; Wang ST; Chan PW; Li Y; Ching J; Chaurasia B; Dogra S; Öhman MK; Takeda K; Sugii S; Pewzner-Jung Y; Futerman AH; Summers SA
    Cell Metab; 2014 Nov; 20(5):919. PubMed ID: 29665397
    [No Abstract]   [Full Text] [Related]  

  • 26. Correction to: Myeloid‑specific deletion of chitinase‑3‑like 1 protein ameliorates murine diet‑induced steatohepatitis progression.
    Kim AD; Kui L; Kaufmann B; Kim SE; Leszczynska A; Feldstein AE
    J Mol Med (Berl); 2023 Dec; 101(12):1627. PubMed ID: 37953339
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of Curcumin Nanoemulsions Stabilized with MAG and DAG-MCFAs in a Fructose-Induced Hepatic Steatosis Rat Model.
    Agame-Lagunes B; Grube-Pagola P; García-Varela R; Alexander-Aguilera A; García HS
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33917706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selected Indonesian Medicinal Plants for the Management of Metabolic Syndrome: Molecular Basis and Recent Studies.
    Arozal W; Louisa M; Soetikno V
    Front Cardiovasc Med; 2020; 7():82. PubMed ID: 32435657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-Alcoholic Fatty Liver Disease and Nutritional Implications: Special Focus on Copper.
    Antonucci L; Porcu C; Iannucci G; Balsano C; Barbaro B
    Nutrients; 2017 Oct; 9(10):. PubMed ID: 29057834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans.
    Inzaugarat ME; De Matteo E; Baz P; Lucero D; García CC; Gonzalez Ballerga E; Daruich J; Sorda JA; Wald MR; Cherñavsky AC
    PLoS One; 2017; 12(3):e0172900. PubMed ID: 28257515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system.
    Lee J; Jo DG; Park D; Chung HY; Mattson MP
    Pharmacol Rev; 2014 Jul; 66(3):815-68. PubMed ID: 24958636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron overload causes oxidative stress and impaired insulin signaling in AML-12 hepatocytes.
    Messner DJ; Rhieu BH; Kowdley KV
    Dig Dis Sci; 2013 Jul; 58(7):1899-908. PubMed ID: 23558563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emodin prevents intrahepatic fat accumulation, inflammation and redox status imbalance during diet-induced hepatosteatosis in rats.
    Alisi A; Pastore A; Ceccarelli S; Panera N; Gnani D; Bruscalupi G; Massimi M; Tozzi G; Piemonte F; Nobili V
    Int J Mol Sci; 2012; 13(2):2276-2289. PubMed ID: 22408453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice.
    Nan YM; Fu N; Wu WJ; Liang BL; Wang RQ; Zhao SX; Zhao JM; Yu J
    Scand J Gastroenterol; 2009; 44(3):358-65. PubMed ID: 18991162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commonly used animal models of non-alcoholic steatohepatitis.
    Fan JG; Qiao L
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):233-40. PubMed ID: 19502161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
    Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melatonin ameliorates methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in rats.
    Tahan V; Atug O; Akin H; Eren F; Tahan G; Tarcin O; Uzun H; Ozdogan O; Tarcin O; Imeryuz N; Ozguner F; Celikel C; Avsar E; Tozun N
    J Pineal Res; 2009 May; 46(4):401-7. PubMed ID: 19552763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance and steatosis in humans.
    Capeau J
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):649-57. PubMed ID: 19195626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic potential of curcumin in non-alcoholic steatohepatitis.
    Shapiro H; Bruck R
    Nutr Res Rev; 2005 Dec; 18(2):212-21. PubMed ID: 19079906
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.